Takeda, Astellas Tumble as Generic-Drug Threat Erodes Profit
May 13 (Bloomberg) — Takeda Pharmaceutical Co. and Astellas Pharma Inc. , Japans largest drugmakers, fell in Tokyo trading after forecasting a slump in profit because of competition from generic versions of their top-selling pills.
